Knowledge Sourcing Intelligence (KSI)
Home/Healthcare/Medical Devices/Molecular Imaging Technologies Market

Molecular Imaging Technologies Market - Strategic Insights and Forecasts (2026-2031)

Evaluation of molecular imaging technologies market expansion supported by advancements in personalized medicine.

CAGR 2026-2031
Ask for a sample
Study Period
2021-2031
Single User License
$3,950
Formats
PDF, Excel, PPT, Dashboard
Pages
158
Data update
2026 refresh included
Report OverviewSegmentationTable of ContentsCustomize Report

The Molecular Imaging Technologies Market is projected to register a strong CAGR during the forecast period (2026-2031).

Highlights:

  1. 1
    More Use of Hybrid Imaging SystemsThe continued growth of hybrid imaging systems (e.g., PET/CT and PET/MRI) is being driven by their ability to create combined anatomical and functional images, which, in turn, leads to better diagnostic accuracy and clinical outcomes.
  2. 2
    :
    Advances in Radiopharmaceutical DevelopmentThe development of targeted radiotracers continues to advance, allowing for the ability to detect very early-stage diseases, primarily in the areas of oncology and neurology.
  3. 3
    :
    Increased Use of Artificial IntelligenceArtificial Intelligence is continually improving the ability to perform image reconstruction, analysis, and interpretation of images, resulting in faster and more accurate diagnosis of persons receiving a molecular imaging examination.
  4. 4
    :
    Growth of Personalised MedicineMolecular imaging is becoming more widely used in providing insight to physicians on how they should treat patients based on the molecular nature of disease biology.

The Molecular Imaging Technologies Market is growing steadily as demand increases for early and precise disease detection. These technologies enable visualization of biological processes at the molecular level, supporting personalized medicine. Advancements in imaging systems and radiopharmaceuticals are driving adoption across oncology, cardiology, and neurology applications.

Molecular imaging is a type of technology that allows to see the activity of cells and molecules in the body without having to invade the body. The three major types of molecular imaging technologies are PET, SPECT, and hybrid systems like PET/CT and PET/MRI. This market is on the rise, with a lot of demand for these technologies for early detection of diseases and personalized medicine, primarily in the areas of oncology, cardiology, and neurology. Advancement in imaging modalities such as all advanced imaging systems to include hybrid systems and AI will continue to improve our ability to diagnose accurately. The increase in healthcare investment and the increasing number of chronic conditions are also helping to drive the growth of this market globally.

Growth Drivers

  • Rising Incidence Rates for Cancer and Chronic Illnesses: The increase in incidence rates of cancers and cardiovascular diseases is creating a new demand for advanced imaging technology used to detect and monitor these diseases prior to a patient presenting with symptoms.

  • Trends in Technology Advancements in Imaging Systems: Advances in the development of imaging modalities and software have led to imaging devices that produce better quality images at faster rates and with increased accuracy than ever before.

  • Increased Demand for Early and Accurate Disease Diagnosis: The focus on the early identification of disease, by most major healthcare organizations, will lead to improved health outcomes and significant reductions in the costs of treating these diseases.

  • Expansion of Nuclear Medicine Applications: The increase in use of nuclear imaging techniques in hospitals and clinics, as well as in academic and clinical research settings, will further support market expansion.

Challenges and Opportunities

  • The imaging market is inhibited by a variety of challenges, including the high costs associated with imaging systems, regulatory constraints surrounding radiopharmaceuticals, and shortages of trained imaging professionals. Some opportunities for the imaging market include the development of innovative tracers, the expansion of emerging markets, and the use of artificial intelligence and digital imaging platforms. Focus on personalized medicine will help accelerate long-term imaging market growth.

Key Development

  • April?2025 : In 2025, Lantheus Holdings achieved a major regulatory milestone when the U.S. Food and Drug Administration accepted its New Drug Application for a new formulation of its PSMA?targeted PET imaging agent. This updated formulation is designed to increase production capacity by roughly 50%, potentially expanding access to advanced prostate cancer imaging and strengthening the company’s molecular imaging portfolio. This step reinforces Lantheus’ position in precision diagnostic radiopharmaceuticals and supports broader clinical availability of PET?based tools for cancer detection and monitoring.

Market Segmentation

The market is segmented by product type, technology, application and geography.

By Product Type: Radiopharmaceuticals

Radiopharmaceuticals are a vital area of medicine because they allow you to see biological processes at the molecular level. Radiopharmaceuticals contain radioactive substances that act as tracers and can be used in imaging methods, including PET and SPECT. These methods allow for the identification of pathology in tissues or organs. Innovation in the development of targeted radiotracers will improve the ability to detect early-stage diseases in 2025, especially in the fields of oncology and neurology. The growth in precision, personalized diagnostics, and therapeutic options is increasing the demand for targeted radiotracers. As a result, the continued innovation in the development of new types of radiopharmaceuticals is important for providing accurate and functional imaging due to their increased specificity and safety.

By Technology: Positron Emission Tomography (PET)

Positron Emission Tomography (PET) is the leading technology for functional imaging because it provides details about the metabolic and biochemical activity of the body. Many healthcare professionals use the PET scan extensively in oncology for the detection and monitoring of response to treatment of tumors. In 2025, integration between PET and CT or MRI PET technologies will enhance the accuracy of disease diagnostics. Improved imaging quality, faster scans and incorporation of artificial intelligence (AI) into imaging will help improve clinical outcomes. PET scanners can detect disease at a very early stage, making PET scanners a significant aspect of current molecular imaging technologies.

By Application: Oncology

Oncology is the largest application area because molecular imaging is a critical component of detecting and diagnosing cancer, as well as monitoring the response to treatment. The use of technologies such as PET and SPECT allows healthcare providers to visualize the metabolic activity of tumors and their ability to spread to other areas of the body. The introduction of targeted radiotracers in the future and the increasing use of hybrid imaging systems (CT and PET or SPECT) will improve oncology diagnostics in 2025. The increasing rates of cancer diagnoses worldwide and increasing focus on the early identification of cancer will continue to drive the use of molecular imaging in oncology and make it a leading application area.

Regional Analysis

North America Market Analysis

North America is leading the way in the use of molecular imaging technology due to its advanced health systems, widespread use of hybrid imaging systems, and use of PET and SPECT technologies. Increasing cancer rates, an increase in the need for precision imaging and diagnostics, and increasing investments in the manufacture and development of AI-enabled technologies in imaging will further fuel growth in this area of medical imaging within hospitals, diagnostic centres and other clinical settings.

South America Market Analysis

The healthcare and, in particular the imaging sectors in South America are expanding at a moderate rate, due to improvements being made throughout the region's healthcare systems and the availability of advanced imaging technologies. Brazil and Argentina, two of the leading countries in South America, are also making significant investments in diagnostic infrastructure. The increasing incidence of chronic illness will fuel demand for molecular imaging, although some limitations to its expansion may occur due to economic challenges. Increasing access to healthcare is supporting sustained growth in the marketplace.

Europe Market Analysis

Europe has a considerable extent of market share within molecular imaging technologies. This is due to the wide range of health care systems within Europe and the increased rates of adoption of advanced molecular imaging technologies. An increased level of investment on behalf of European governmental bodies to promote nuclear medicine and molecular imaging for the early detection and diagnosis of illnesses provides additional support for the development of the market for molecular imaging technologies. Increasing focus on personalized medicine and the increasing chronic illness burden on the healthcare system continue to support increased demand for molecular imaging technologies. Additionally, increased cooperation and partnerships within research, as well as regulatory approval and endorsement, are additional factors supporting continued innovation and accelerated adoption of molecular imaging technologies throughout Europe.

SEGMENT SHARE DISTRIBUTION (ILLUSTRATIVE)
Market Share Breakdown — By Product Type
Unlock Exact Segment Splits →
Imaging Systems
Radiopharmaceuticals
Software & Services
Bar lengths are illustrative. The full report gives historical and forecast revenue for each segment.
HISTORICAL & FORECAST DATA TABLE (ILLUSTRATIVE)
By Product Type — Revenue by Year (2026–2031)
Segment202620272028202920302031CAGR (%)
Imaging Systems
Radiopharmaceuticals
Software & Services
Total Market Size——Ask for a sample
Unlock Full Historical & Forecast Excel Databook (2026–2031)
Download Sample Excel →

Middle East and Africa Market Analysis

Middle Eastern and African healthcare markets are also demonstrating early signs of growth as the region continues to invest in healthcare and implement advanced diagnostic technologies. In many countries throughout the Middle East, governmental efforts are geared towards modernising their healthcare infrastructure. In many parts of Africa, improving access to medical imaging has been identified as a key factor to increasing usage. Ongoing increases in the burden of disease combined with public and private sector organisations promoting the benefits of early diagnosis are expected to result in stable growth in the diagnostic imaging marketplace in these regions.

Asia Pacific Market Analysis

The Asia-Pacific region has the highest rate of growth in the market for molecular imaging technologies. The expansion of healthcare systems and an increased level of investment in advanced diagnostic procedures will continue to spur growth in the region. Key countries such as China, India and Japan expanding their use of molecular imaging technology to improve the detection and diagnosis of diseases. Increased public awareness of the benefits of early diagnosis of disease, combined with the increasing patient population, are important contributors to the accelerated growth in this region. Government support for healthcare modernization initiatives will also continue to support the expansion of the market for molecular imaging systems throughout the Asia-Pacific region.

List of Companies

·      Siemens Healthineers

·      GE HealthCare

·      Philips Healthcare

·      Canon Medical Systems

·      Bracco Imaging

·      Curium Pharma

·      Lantheus Holdings

·      Eckert & Ziegler

·      Bayer AG

·      Fujifilm Healthcare

Siemens Healthineers

Siemens Healthineers is one of the top companies providing innovative solutions for molecular imaging, particularly through their PET/CT and SPECT systems. The company has committed to incorporating artificial intelligence into their products as they move forward into 2025 and is also focused on hybrid imaging technologies, which will ultimately aid in accuracy and speed of diagnostic processes. Their innovations drive the usage of precision medicine (specifically in oncology and neurology), thereby improving their global market share as well.

GE HealthCare

GE HealthCare's contribution to the molecular imaging market is evident through its extensive portfolio of PET, SPECT, and hybrid imaging systems. GE HealthCare is committed to AI-enabled imaging platforms and uses advanced visualization tools to enhance the quality of clinical decision-making for physicians. GE HealthCare's continued expansion into molecular imaging for the rest of this decade will contribute to the development of diagnostic capabilities that support the early identification of disease and personalized treatment options for patients across many therapeutic areas.

Molecular Imaging Technologies Market Scope:

Report Metric Details
Forecast Unit Billion
Growth Rate Ask for a sample
Study Period 2021 to 2031
Historical Data 2021 to 2024
Base Year 2025
Forecast Period 2026 – 2031
Segmentation Product Type, Technology, Application, Geography
Companies
  • Siemens Healthineers
  • GE HealthCare
  • Philips Healthcare
  • Canon Medical Systems
  • Bracco Imaging
  • Curium Pharma
  • Lantheus Holdings
  • Eckert & Ziegler
  • Bayer AG
  • Fujifilm Healthcare
Customization Scope 15% Free Customization included with purchase — Request Custom Breakdown →
Sample & Data Access PDF Sample, Excel Databook & Analyst Briefing — Download Free Sample →

Need country-level data or a custom regional split for your target market?Request Regional Data →

Market Segmentation

By Product Type

Imaging Systems
Radiopharmaceuticals
Software & Services

By Technology

Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Hybrid Imaging (PET/CT, SPECT/CT)

By Application

Oncology
Cardiology
Neurology
Orthopedics

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

Table of Contents

  1. 1. EXECUTIVE SUMMARY

  2. 2. MARKET SNAPSHOT

    1. 2.1. Market Overview

    2. 2.2. Market Definition

    3. 2.3. Scope of the Study

    4. 2.4. Market Segmentation

  3. 3. BUSINESS LANDSCAPE

    1. 3.1. Market Drivers

    2. 3.2. Market Restraints

    3. 3.3. Market Opportunities

    4. 3.4. Porter’s Five Forces Analysis

    5. 3.5. Industry Value Chain Analysis

    6. 3.6. Policies and Regulations

    7. 3.7. Strategic Recommendations

    8. 3.8. Product Pipeline Analysis

    9. 3.9. Incidence and Prevalence Analysis

    10. 3.10. Patent Analysis

  4. 4. TECHNOLOGICAL OUTLOOK

  5. 5. MOLECULAR IMAGING TECHNOLOGIES MARKET BY PRODUCT TYPE

    1. 5.1. Introduction

    2. 5.2 Imaging Systems

    3. 5.3. Radiopharmaceuticals

    4. 5.4. Software & Services

  6. 6. MOLECULAR IMAGING TECHNOLOGIES MARKET BY TECHNOLOGY

    1. 6.1. Introduction

    2. 6.2. Positron Emission Tomography (PET)

    3. 6.3. Single Photon Emission Computed Tomography (SPECT)

    4. 6.4. Hybrid Imaging (PET/CT, SPECT/CT)

  7. 7. MOLECULAR IMAGING TECHNOLOGIES MARKET BY APPLICATION

    1. 7.1. Introduction

    2. 7.2. Oncology

    3. 7.3. Cardiology

    4. 7.4. Neurology

    5. 7.5. Orthopedics

  8. 8. MOLECULAR IMAGING TECHNOLOGIES MARKET BY GEOGRAPHY

    1. 8.1. Introduction

    2. 8.2. North America

      1. 8.2.1. USA

      2. 8.2.2. Canada

      3. 8.2.3. Mexico

    3. 8.3. South America

      1. 8.3.1. Brazil

      2. 8.3.2. Argentina

      3. 8.3.3. Others

    4. 8.4. Europe

      1. 8.4.1. United Kingdom

      2. 8.4.2. Germany

      3. 8.4.3. France

      4. 8.4.4. Spain

      5. 8.4.5. Others

    5. 8.5. Middle East and Africa

      1. 8.5.1. Saudi Arabia

      2. 8.5.2. UAE

      3. 8.5.3. Others

    6. 8.6. Asia Pacific

      1. 8.6.1. China

      2. 8.6.2. India

      3. 8.6.3. Japan

      4. 8.6.4. South Korea

      5. 8.6.5. Indonesia

      6. 8.6.6. Thailand

      7. 8.6.7. Others

  9. 9. COMPETITIVE ENVIRONMENT AND ANALYSIS

    1. 9.1. Major Players and Strategy Analysis

    2. 9.2. Market Share Analysis

    3. 9.3. Mergers, Acquisitions, Agreements, and Collaborations

    4. 9.4. Competitive Dashboard

  10. 10. COMPANY PROFILES

    1. 10.1. Siemens Healthineers

    2. 10.2. GE HealthCare

    3. 10.3. Philips Healthcare

    4. 10.4. Canon Medical Systems

    5. 10.5. Bracco Imaging

    6. 10.6. Curium Pharma

    7. 10.7. Lantheus Holdings

    8. 10.8. Eckert & Ziegler

    9. 10.9. Bayer AG

    10. 10.10. Fujifilm Healthcare

  11. 11. APPENDIX

    1. 11.1. Currency

    2. 11.2. Assumptions

    3. 11.3. Base and Forecast Years Timeline

    4. 11.4. Key benefits for the stakeholders

    5. 11.5. Research Methodology

    6. 11.6. Abbreviations

Trusted by industry leaders
AmazonABBFujifilmHitachiMcKinseyAmazonABBFujifilmHitachiMcKinsey
Report IDKSI-008434
Last updated
Pages158

Frequently asked questions

What is the projected growth trajectory for the Molecular Imaging Technologies Market during the 2026-2031 forecast period?

The Molecular Imaging Technologies Market is projected to register a strong Compound Annual Growth Rate (CAGR) during the 2026-2031 forecast period. This robust growth is primarily driven by the increasing demand for early and precise disease detection and the rising prevalence of chronic conditions and cancers, supporting personalized medicine initiatives.

Which key disease applications are primarily driving the adoption of molecular imaging technologies, as analyzed in the 2026-2031 strategic forecasts?

The demand for molecular imaging technologies is primarily driven by applications in oncology, cardiology, and neurology. These technologies enable visualization of biological processes at the molecular level, crucial for early disease detection and personalized treatment strategies in these critical areas.

What are the major types of molecular imaging technologies covered in the report, and what emerging trends are noted among them?

The three major types of molecular imaging technologies are PET, SPECT, and hybrid systems such as PET/CT and PET/MRI. The report highlights the continued growth and increased use of hybrid imaging systems, which provide combined anatomical and functional images for improved diagnostic accuracy and clinical outcomes.

How are technological advancements, specifically in hybrid imaging and Artificial Intelligence, shaping the future of the Molecular Imaging Technologies Market from 2026 to 2031?

Technological advancements, particularly in hybrid imaging systems and the increased use of Artificial Intelligence (AI), are significantly shaping the market. Hybrid systems like PET/CT and PET/MRI offer enhanced diagnostic accuracy, while AI continually improves image reconstruction, analysis, and interpretation, leading to faster and more precise diagnoses.

What are the principal growth drivers identified for the Molecular Imaging Technologies Market in the 2026-2031 strategic insights?

Key growth drivers include the rising incidence rates of cancers and cardiovascular diseases, creating demand for advanced imaging for early detection. Additionally, increased healthcare investment, continuous advancements in imaging systems, and a strong focus on early and accurate disease diagnosis by major healthcare organizations are fueling market expansion.

What role does personalized medicine play in the growth and strategic direction of the Molecular Imaging Technologies Market (2026-2031)?

Personalized medicine is a significant growth driver, as molecular imaging becomes more widely used to provide physicians with crucial insights into treatment approaches based on the molecular nature of disease biology. This enables tailored patient care and is a core factor in the market's strategic expansion and innovation.

Cite this report

Knowledge Sourcing Intelligence. (Mar 2026). Molecular Imaging Technologies Market - Strategic Insights and Forecasts (2026-2031). https://www.knowledge-sourcing.com/report/molecular-imaging-technologies-market

Get notified when this report is updated